層粘連蛋白γ2(LAMC2)多克隆抗體
Polyclonal Antibody to Laminin Gamma 2 (LAMC2)
B2T; EBR2; EBR2A; LAMB2T; LAMNB2; Kalinin/nicein/epiligrin 100 kDa subunit; Cell-scattering factor 140 kDa subunit; Ladsin 140 kDa; Large adhesive scatter factor 140 kDa
- 編號PAC083Hu01
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 RPC083Hu01-層粘連蛋白γ2(LAMC2)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度0.5mg/ml
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 630 ¥ 1470 ¥ 2100 ¥ 5250 ¥ 21000
- 欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Used in DAB staining on fromalin fixed paraffin-embedded Kidney tissue
-
Figure. Western Blot; Sample: Recombinant LAMC2, Human.
-
Western Blot; Sample: Human Lung lysate;
Primary Ab: 5μg/ml Rabbit Anti-Human LAMC2 Antibody
Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19) -
Knockout Varification:
Lane 1: Wild-type A431 cell lysate;
Lane 2: LAMC2 knockout A431 cell lysate;
Predicted MW: 121,130kd
Observed MW: 120kd
Primary Ab: 5μg/ml Rabbit Anti-Human LAMC2 Antibody
Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19) -
Western Blot; Sample: Human A431 cell lysate; <br/>Primary Ab: 5μg/ml Rabbit Anti-Human LAMC2 Antibody<br/>Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody<br/>(Catalog: SAA544Rb19)
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對LAMC2的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別LAMC2。
用法
Western blotting: 0.01-5μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPC083Hu02 | 層粘連蛋白γ2(LAMC2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPC083Hu05 | 層粘連蛋白γ2(LAMC2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPC083Hu01 | 層粘連蛋白γ2(LAMC2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPC083Hu03 | 層粘連蛋白γ2(LAMC2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAC083Hu01 | 層粘連蛋白γ2(LAMC2)多克隆抗體 | WB; IHC; ICC; IP. |
| PAC083Hu03 | 層粘連蛋白γ2(LAMC2)多克隆抗體 | WB; IHC; ICC; IP. |
| PAC083Hu02 | 層粘連蛋白γ2(LAMC2)多克隆抗體 | WB; IHC; ICC; IP. |
| MAC083Hu22 | 層粘連蛋白γ2(LAMC2)單克隆抗體 | WB |
| MAC083Hu21 | 層粘連蛋白γ2(LAMC2)單克隆抗體 | WB |
| SEC083Hu | 層粘連蛋白γ2(LAMC2)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMC083Hu | 層粘連蛋白γ2(LAMC2)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Molecular & Cellular Proteomics | LAMC2: A promising new pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues [Mcponline: 023507] |
| Clinical Cancer Research | Validation of Biomarkers That Complement CA19.9 in Detecting Early Pancreatic Cancer [Pubmed:25239611] |
| British journal of cancer | Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer [PubMed: 26180921] |
| U.S. National Library of Medicine | Prognostic significance of circulating laminin gamma2 for early-stage non-small-cell lung cancer [pubmed:27462170] |
| American Journal of Obstetrics & Gynecology MFM | PRETERM BIRTH PREDICTION IN ASYMPTOMATIC WOMEN AT MID-GESTATION USING A PANEL OF NOVEL PROTEIN BIOMARKERS: The Prediction of PreTerm?… [] |
| Biomarkers of Preterm Birth [] |
留言咨詢
